+1,741.1%
GSK vs HUBB
+140,477.7%
-138,736.6%
-55.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | HUBB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -2.9% | +2.8% | -0.1% |
| 7D | -1.3% | -3.9% | +2.6% | -1.3% |
| 30D | +2.7% | -8.0% | +10.7% | +2.8% |
| 3M | +2.7% | -16.7% | +19.5% | +2.8% |
| 6M | +3.3% | -11.0% | +14.4% | +3.4% |
| YTD | +6.5% | -3.6% | +10.0% | +6.4% |
| 1Y | +10.7% | -0.7% | +11.4% | +10.6% |
| 3Y | +64.4% | +52.3% | +12.0% | +63.8% |
| 5Y | +46.7% | +118.9% | -72.3% | +45.8% |
| 10Y | +109.4% | +364.7% | -255.3% | +107.0% |
| All | +1,741.1% | +140,477.7% | -138,736.6% | +1,859.7% |
Cumulative growth
Daily Returns
Daily percentage return beside HUBB.
Daily Out/Under-Performance
Portfolio return minus HUBB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HUBB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded HUBB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling